Definition
A paid-in capital increase is when a company issues new shares to raise money for its business and sells them to investors. It's a classic way to grow equity (the company's own capital) without borrowing from a bank.
What Happens When the Pizza Has More Slices
Picture four friends sharing one pizza cut into four slices, one each. Then someone cuts the pizza into eight slices and says they'll sell the other four slices to new friends for cash. With more slices, your slice makes up only half as much of the whole pizza. The money from selling the new slices could buy more pizza. But if the slices were sold for less than they're worth, your share ends up worth less.
In the stock market, this is called dilution of ownership value. When a company prints lots of new shares, existing shareholders who don't buy any see their ownership percentage drop. If the new shares are issued below the market price, each share can lose value too. That's why a stock price often dips for a while when a paid-in capital increase is announced.
On top of that, companies usually issue new shares at a discount to the market price so they sell well. Under Korean regulations, a public offering can be discounted by up to 30%. For existing shareholders, their own shares lose value while cheap shares flood the market. It's natural to feel uneasy.
Is It Always Bad News?
So is a paid-in capital increase always bad news for shareholders? The answer depends on what the company does with the new money.
Say a chip maker is flooded with orders and doesn't have enough factories. If it raises money to build a state-of-the-art plant and fund research, that can be a good sign. Right now your slice gets smaller. But the new plant could earn big profits and double the size of the whole pizza.
On the other hand, it's a warning sign if the company issues shares to pay off debts that piled up because sales were weak, or to cover day-to-day running costs. The pizza isn't getting any bigger. The company is just cutting it into more slices. In the end, whether a capital increase is medicine or poison depends on the company's growth potential.
To Be More Precise
To be more precise, the market reacts very differently depending on who the new shares are sold to. There are three main methods, based on who is allowed to buy.
The first is a rights offering (called "shareholder allocation" in Korea). Existing shareholders get first dibs on buying the new shares at a lower price. The second is a public offering, which is open to anyone in the general public, not just current shareholders.
The third is a private placement (called "third-party allocation" in Korea). The company sells only to a specific company or investor it has chosen. Suppose a global giant invests because it believes in the company's technology and wants to be a partner. The market may see that as great news, and the stock price can even jump.
Common misconceptions
A paid-in capital increase always hurts the stock price and is bad news.
If the new money builds a promising factory or grows the business, the company's value can rise over time. The stock price can then climb even higher.
A paid-in capital increase makes a company's debt go up.
The money comes from investors (equity), not from borrowing (debt). The company has no duty to pay interest or repay principal.
Where you meet it
A biotech startup raises money from its shareholders to pay for clinical trials of a new drug.
An electric-vehicle parts maker decides on a private placement aimed at a large corporation, as part of a strategic partnership.
In one sentence
A paid-in capital increase means selling new shares for cash. If the money is invested well in future growth, it can be an opportunity.